Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Disrupted Sleep, Neuroendocrine Status and the Behavioral Symptoms of Alzheimer's Disease (AD)

NCT01920672 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT01920672
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01920672 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Disrupted Sleep, Neuroendocrine Status and the Behavioral Symptoms of Alzheimer's Disease (AD)
Lead sponsor
Johns Hopkins University
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2013
Completion date
June 30, 2015
Enrollment
82 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease